Last deal

$750K

Amount

Venture - Series Unknown

Stage

05.09.2012

Date

1

all rounds

$750K

Total amount

date founded

Financing round

General

About Company
ProThera Biologics develops bio-therapeutics for treating inflammatory diseases.

Industry

Sector :

Subsector :

founded date

01.01.2001

Number of employees

Company Type

For Profit

Last funding type

Venture - Series Unknown

IPO status

Private

Description

The Rhode Island-based company focuses on Inter-alpha Inhibitor Proteins (IAIP) found in human plasma, which play a crucial role in regulating the immune response. Founded in 2001 by Yow-Pin Lim and Douglas C. Hixson, both actively involved in biomedical research, ProThera Biologics aims to create theranostic and therapeutic biomolecules that modulate multiple pathways to control inflammation. Their products have the potential to effectively treat life-threatening inflammatory diseases like sepsis and cancer.
Similar Companies
1000
Therini Bio

Therini Bio

Therini Bio, Inc. is developing novel therapeutics for neuroinflammatory diseases caused by vascular dysfunction.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

San Francisco, CA, USA

total rounds

6

total raised

$91.97M
TheraSource

TheraSource

TheraSource is a biotech company developing new anti-inflammatory therapeutics for human diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Manhasset, NY, USA

total rounds

1

total raised

$3M
ILIAS Biologics

ILIAS Biologics

ILIAS Biologics develops exosome-based therapeutics for hard-to-treat inflammatory and metabolic diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Therapeutics, Health Care

Location

Daejeon, Jeong-dong, Daejeon, South Korea

total rounds

2

total raised

$37.6M
Aliada Therapeutics

Aliada Therapeutics

Aliada Therapeutics is a biotechnology company developing novel therapies to treat central nervous system diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Therapeutics, Health Care

Location

Boston, MA, USA

total rounds

1

total raised

$32M

Financials

Funding Rounds
1
1

Number of Funding Rounds

$750K

Money Raised

Their latest funding was raised on 05.09.2012. Their latest investor National Institutes of Health. Their latest round Venture - Series Unknown

Date 
Funding Round 
Investors 
Money Raised 
Lead 
05.09.2012
2
$750K
Co-Investors
Investors
2
0

Number of lead investors

2

Number of investors

Investor 
Lead 
Round 
Partners 
No
Venture - Series Unknown
No
Venture - Series Unknown
National Institutes of Health

National Institutes of Health

NIH conducts research to improve health and reduce illness and disability.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Software, Government

Location

Bethesda, MD, USA

total rounds

1

total raised

$5M

count Of Investments

827

count Of Exists

31
Slater Technology Fund

Slater Technology Fund

The Slater Technology Fund is a venture capital investment fund that focuses on supporting early-stage technology ventures in Rhode Island.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Venture Capital, Financial Services

Location

Providence, RI, USA

total rounds

1

total raised

$300K

count Of Investments

45

count Of Exists

10

People

Employee Profiles
5
Richard Andrews

Richard Andrews

Director

Yow Lim

Yow Lim

Founder, President & CSO

Denice Spero

Denice Spero

President and Chief Business Officer

Douglas Hixson

Founder

Activity

Recent News
0